Deutsche Bank: Not Much Upside Ahead (NYSE:DB)

franz12 Deutsche Bank (NYSE:DB) has improved its performance in recent quarter supported by rising rates, a trend that is expected to reverse in the near future. While its shares remain cheap compared to other European banks, this is justified by the bank’s low profitability level. As I’ve covered in a previous article, Deutsche Bank is…

Read More

Hawkins: Modest Upside Potential Despite Positive Growth Outlook (NASDAQ:HWKN)

zorazhuang Synopsis Hawkins, Inc.’s (NASDAQ:HWKN) historical financial results have shown robust revenue growth and strong bottom-line margins. For its 2Q24 results, there was a slight decline in revenue growth due to the sale of its consumer bleach packaging business. However, margins grew at double-digit rates, resulting in an increase in diluted EPS. Looking ahead, its…

Read More

Gambling.com: Recent Selloff Unwarranted, Strong Upside With Solid Financial Performance

svetikd Executive Summary I believe that Gambling.com’s (NASDAQ:GAMB) recent selloff is an overreaction, overlooking the company’s strong fundamentals and promising growth trajectory. GAMB, a growing player in digital marketing within the sports betting industry, has demonstrated strong financial performance, including very strong revenue growth in the last year. The online gambling industry, particularly in the…

Read More

Sempra: An Attractive Utility With LNG Upside (NYSE:SRE)

Michael Vi/iStock Editorial via Getty Images Shares of Sempra (NYSE:SRE) have been a poor performer over the last year, losing about 5% of their value. Higher interest rates have weighed on utilities and dividend-oriented stocks. While higher interest expense has had a negative impact on results, SRE has a strong growth position, which should enable…

Read More

Transcontinental: Q4 Results Support Dividend Yield And Upside (TSX:TCL.A:CA)

beingbonny/iStock via Getty Images Investment Thesis Transcontinental (TSX:TCL.A:CA) is a flexible packaging and printing company in North America. It reported its quarterly results and has managed to deliver decent performance despite the macroeconomic pressures. I believe the company can further grow in the future as it has highly focused on the commercialization of recyclable flexible…

Read More

Mistras Group: Trading Cheaply With Scope For Upside (NYSE:MG)

jimfeng Investment thesis Our current investment thesis is: MG has performed poorly but is not dead-and-buried. There is clear scope for an improvement in financial performance, particularly when considering the increase in infrastructure spending expected. There is, however, a clear execution risk that is not mitigated. For this reason, valuation is of utmost importance to…

Read More

Despite Many Headwinds, Micron Could Deliver A Decent Upside (NASDAQ:MU)

vzphotos Thesis Micron Technology, Inc. (NASDAQ:MU) stands out as one of the most cyclical stocks I’ve encountered, exhibiting significant fluctuations during market expansions and contractions. However, since December 30, 2022, coinciding with the 2023 market rally, the stock has surged by approximately 73%. In this analysis, I will illustrate, using valuation models, why Micron is…

Read More

VUG: Recent Months Have Shown Very Limited Upside For 2024

Douglas Rissing/iStock via Getty Images The Vanguard Growth Index Fund ETF Shares (NYSEARCA:VUG) is one of the most popular choices for investors looking for a basket of high quality growth names. Instead of picking individual growth stocks and bearing significant idiosyncratic risk, the exchange-traded fund (“ETF”) gives you exposure to many of the most popular…

Read More

CVS Health: Risk/Reward Highly Skewed To The Upside (NYSE:CVS)

LPETTET Company Overview CVS Health Corporation (NYSE:CVS) is a US-based integrated provider of healthcare solutions across the value chain from pharmacies and primary care to health insurance for commercial and governmental customers. It is the second largest healthcare services provider in the US behind UnitedHealthcare with more than 300k employees and $322bn in revenue as…

Read More

13% Dividend Yield And 12% Upside

Portra/E+ via Getty Images Our objective is to enhance the worth of our portfolio. Our financial resources are finite, as our portfolio must operate within real-world constraints. Consequently, this necessitates difficult decisions, occasionally requiring us to part with shares we’d prefer to retain. In instances like this, we relinquish a favorable opportunity to seize an…

Read More

Mowi: Norwegian Salmon Still Has Upside (OTCMKTS:MNHVF)

nhattienphoto Dear readers, Mowi’s (OTCPK:MNHVF) 2Q23 was a record-breaking quarter with high revenue and stable expenses, indicating plenty of upside potential. Like other salmon companies, the company’s valuation is primarily influenced by salmon pricing trends, and the company has maintained strong pricing and contract discipline over time here. In this article, I’m going to look…

Read More

Volkswagen: Lamborghini Upside and EU volume recovery (OTCMKTS:VLKPF)

jetcityimage/iStock Editorial via Getty Images Post Q3 results, we still need to update our readers on Volkswagen (OTCPK:VLKAF) (OTCPK:VWAPY) (OTCPK:VWAGY). The company is Europe’s largest carmaker and a leading player in commercial vehicles. Volkswagen’s portfolio comprises 12 brands and covers all segments, from heavy trucks to supercars such as Bentley and Lamborghini. Today, we aim…

Read More

Exxon Has Huge Production Upside For 2024 (NYSE:PXD)

Michael M. Santiago It has been about a month since Exxon Mobil (NYSE:XOM) and Pioneer Natural Resources (NYSE:PXD) announced their $59.5b merger. This highly accretive merger is expected to close sometime in 1h24 and will significantly bolster Exxon’s upstream daily production volumes by 16% and total upstream revenue by 30% as well as provide margin-expanding…

Read More

NovoCure Stock: Significant Upside Even Without A Breakthrough (NASDAQ:NVCR)

FatCamera NovoCure Limited (NASDAQ:NVCR) is an oncology company that has pioneered a novel therapy for solid tumors known as Tumor Treating Fields (TTFields). Central to their business model is not just the provision of this innovative treatment, but also the comprehensive patient support services they offer. These services include training and technical support for Optune…

Read More

Gravity: A Classic Mohnish Pabrai – Huge Upside Limited Downside Risk (NASDAQ:GRVY)

Arsenii Palivoda Investment Thesis Gravity Co. (NASDAQ:GRVY), an online and mobile gaming developing company, has surged in sales thanks to the Ragnarok series. With a stable leadership team and strategic market entry, it’s poised for growth in the expanding mobile gaming market. Gravity’s attractive valuation, low P/E ratio, and strong financial position make it an…

Read More